Biohaven Pharmaceuticals said a new type of experimental medicine reduced levels of a disease-causing immune molecule by up ...

Merck has struck a $1.3 billion deal to buy Eyebiotech, a move that would push the big drugmaker into the large and growing ...

A new study found that Wegovy was linked to a 50% and 56% lower risk of incidence and recurrence of alcohol use disorder over ...

Health insurers are boasting to investors about using AI but refusing to discuss what models they’re using, how those models ...

Unless Medicaid raises its payments to rural psychiatrists, mental health clinics across the heartland will disappear, and ...

When it comes to childhood and young adulthood, most people in the U.S. think of carefree times of life with few major ...

STAT teamed up with Word In Black, a network of 10 Black news publishers, to report over the past year on the impact of new ...

As scientists celebrate gene therapy's ability to enable hearing, deaf people are feeling a familiar dread: Are we endangered ...

Get a preview of STAT's coverage for #ASCO2024, from events to a pop-up newsletter to the buzziest abstracts that will be ...

A new dark money group called “Defend our DNA” has started to run some social media ads supporting the BIOSECURE Act.

Making telehealth platforms more accessible to people with hearing loss by including captioning would transform the ...

Almost a dozen pharmaceutical companies have lost sensitive customer data due to a supply chain cyberattack that trickled ...